| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.27 | 0.05 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.14 | 0.3 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.11 | 0.6 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.11 | 0.5 |